- €45.24bn
- €54.23bn
- €21.10bn
Annual balance sheet for Merck KGaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | Interim Report | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,685 | 1,719 | 2,077 | 2,791 | 3,016 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4,345 | 4,688 | 4,581 | 4,591 | 4,406 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 10,982 | 12,201 | 12,393 | 13,450 | 13,230 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,217 | 8,204 | 9,056 | 10,025 | 9,940 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 45,362 | 48,535 | 48,495 | 51,596 | 51,527 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10,432 | 9,514 | 8,699 | 11,295 | 9,042 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 24,024 | 22,608 | 21,816 | 21,682 | 22,935 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 21,338 | 25,927 | 26,679 | 29,914 | 28,592 |
| Total Liabilities & Shareholders' Equity | 45,362 | 48,535 | 48,495 | 51,596 | 51,527 |
| Total Common Shares Outstanding |